Treatment of Group A Streptococcus Pharyngitis
Penicillin V or amoxicillin for 10 days is the first-line treatment for confirmed Group A Streptococcus pharyngitis, with penicillin remaining the drug of choice due to its narrow spectrum, proven efficacy in preventing rheumatic fever, excellent safety profile, and low cost. 1
First-Line Treatment for Patients Without Penicillin Allergy
Oral penicillin V is the gold standard treatment based on decades of evidence demonstrating prevention of acute rheumatic fever, which is the primary goal of therapy to reduce morbidity and mortality. 1
Recommended Dosing:
- Children: 250 mg two or three times daily for 10 days 1
- Adolescents and adults: 250 mg four times daily OR 500 mg twice daily for 10 days 1
- Strength of recommendation: Strong, high quality evidence 1
Amoxicillin is an equally effective alternative, often preferred in young children due to better palatability of the suspension. 1
Recommended Dosing:
- 50 mg/kg once daily (maximum 1,000 mg) for 10 days 1
- Alternative: 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days 1
- Strength of recommendation: Strong, high quality evidence 1
Intramuscular benzathine penicillin G should be strongly considered when adherence to a 10-day oral regimen is questionable, as this single-dose option ensures complete treatment. 1
Recommended Dosing:
- <60 lb (27 kg): 600,000 units as a single dose 1
- ≥60 lb: 1,200,000 units as a single dose 1
- Strength of recommendation: Strong, high quality evidence 1
Treatment for Patients With Penicillin Allergy
The choice of alternative antibiotic depends on the type of penicillin allergy. 1
For Non-Immediate Hypersensitivity (Non-Anaphylactic):
First-generation cephalosporins are acceptable alternatives as they can be used safely in patients without immediate-type hypersensitivity reactions. 1
- Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days 1
- Cefadroxil: 30 mg/kg once daily (maximum 1 g) for 10 days 1
- Strength of recommendation: Strong, high quality evidence 1
For Immediate Hypersensitivity (Anaphylactic):
Avoid all beta-lactam antibiotics including cephalosporins in patients with immediate hypersensitivity reactions. 1
Clindamycin is the preferred non-beta-lactam option:
- 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days 1
- Strength of recommendation: Strong, moderate quality evidence 1
Macrolides (azithromycin or clarithromycin) are alternatives, but with important caveats:
- Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days 1
- Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days 1
- Strength of recommendation: Strong, moderate quality evidence 1
Critical Caveat About Macrolides:
Resistance of Group A Streptococcus to macrolides is well-documented and varies geographically and temporally. 1 While resistance rates remain below 5% in most of North America, there are regions with significantly higher resistance. 1, 2 This makes macrolides less reliable than other options when available.
Duration of Therapy
The 10-day treatment duration is essential for maximal pharyngeal eradication of Group A Streptococcus and prevention of rheumatic fever. 1 This duration has been validated through decades of clinical experience and remains the standard despite studies suggesting shorter courses with certain newer agents. 1
The only exception is azithromycin, which is approved for 5 days due to its prolonged tissue half-life, though this comes with the caveat of potential resistance. 1
Treatment Goals and Outcomes
The primary objectives of antibiotic therapy, in order of importance for morbidity and mortality reduction, are:
- Prevention of acute rheumatic fever - the most critical outcome 1
- Prevention of suppurative complications (peritonsillar abscess, cervical lymphadenitis, mastoiditis) 1
- Reduction of symptom duration and severity 1
- Decreased transmission to close contacts 1
- Rapid return to normal activities 1
Special Considerations
Chronic Carriers
Routine antibiotic treatment is NOT recommended for chronic streptococcal carriers who have repeated positive throat cultures but are asymptomatic or experiencing viral infections. 1
Treatment of carriers should only be considered in specific high-risk situations:
- Community outbreak of acute rheumatic fever, post-streptococcal glomerulonephritis, or invasive GAS infection 1
- Outbreak in a closed/partially closed community 1
- Personal or family history of acute rheumatic fever 1
- Excessive family anxiety about GAS infections 1
- When tonsillectomy is being considered solely due to carrier state 1
For carrier eradication when indicated, clindamycin 20-30 mg/kg/day in three doses for 10 days is the most effective single-agent regimen. 1
Follow-Up Testing
Routine post-treatment testing is NOT recommended for asymptomatic patients who have completed appropriate antibiotic therapy. 1 The exception is when special circumstances exist (outbreak situations, history of rheumatic fever). 1
Household Contacts
Routine testing and treatment of asymptomatic household contacts is NOT recommended. 1 Only symptomatic contacts should be evaluated and tested. 1
Common Pitfalls to Avoid
Do not use sulfonamides or tetracyclines - high resistance rates and frequent treatment failures make these inappropriate choices. 1
Do not prescribe shorter courses of standard antibiotics (penicillin, amoxicillin, cephalosporins) - the 10-day duration is necessary for adequate eradication despite patient preference for shorter courses. 1
Do not add corticosteroids to antibiotic therapy for routine GAS pharyngitis - they are not recommended. 1
Avoid aspirin in children for symptomatic relief due to Reye syndrome risk. 1
Do not use cephalosporins in patients with immediate-type penicillin hypersensitivity - cross-reactivity can occur with serious consequences. 1
Adjunctive Symptomatic Treatment
Analgesics and antipyretics (acetaminophen or NSAIDs) can be used for moderate to severe symptoms or high fever, but are adjunctive only and do not replace antibiotic therapy. 1